Date

23-24 November, 2019

Location

Kuala Lumpur, Malaysia

Cancer Conference Overview


Larix International is a group of ranking publishers and organizer’s for scientific conferences around the globe nesting well-known Doctors, Engineers, Scientists, and Industrialists. Larix is a self-functioning, independent organization wholly focused on arranging conferences in multi-disciplines of research on various science fields. The conferences are administered by global influential scientists and scientific excellence. We are even open for the upcoming scientists and scholars, who are in need of a platform to give their voice a much needed larger volume.

What to expect

  • Engage with the most experienced and influential community.
  • Learn how to use technologies to reduce time to market, produce stronger and lighter parts, improve efficiency, reduce waste and cost, and create complex geometries.
  • Consult with industry experts before you make equipment decisions.
  • Network with hundreds of attendees and see how they’re addressing challenges.
  • Experience the most respected additive conference, with over 20+ knowledgeable speakers.
  • Collaborate with users to advance applications for technologies.

IMPORTANT DATES


  • Abstract Submission opens:

    April 10, 2019


  • Abstract Submission Deadline:

    Nov 05, 2019


  • Standard Registration opens:

    April 10, 2019


  • Standard Registration Deadline:

    Nov 05, 2019

Session 1: Cancer Biology

 

Cancer systems biology encompasses the application of systems biology approaches to cancer analysis, so as to check the sickness as a complex adaptive system with rising properties at multiple biological scales. Cancer systems biology represents the application of systems biology approaches to the analysis of how the intracellular network of traditional cells are rattled during carcinogenesis to develop effective predictive models that can assist scientists and clinicians in the validations of new therapies and drugs. Tumours are characterized by genomic and epigenetic instability that alters the functions of many different molecules and networks in a single cell as well as altering the interactions with the local environment. Cancer systems supports the utilization of process and mathematical strategies to decipher the complexness in tumorigenesis additionally as cancer heterogeneousness.

Session 2: Cancer Diagnosis

 

Cancer is considered to be the main reason for deaths across the world.

The cure for cancer is still a matter of research. However, there are few curing techniques available only if the person is diagnosed at the early growth stages.

So cancer identification becomes a really necessary a part of associate individual’s survival. Since the cancer cells exhibit properties of a normal cell until it reaches malignant stages, it becomes difficult to diagnose. However few symptoms will act just like the signals for the cancer growth. Once these symptoms are encountered one can endure diagnosing techniques like diagnostic test, Radiography etc. Through these strategies, the practician are going to be ready to predict the stage of cancer and survivability of the patients.

Session 3: Cancer Immunotherapy & Vaccine

 

Cancer therapy (Immuno-oncology or Immunooncology) is that the use of the system to treat cancer. Immunotherapies can be categorised as active, passive or hybrid (active and passive). These approaches exploit the very fact that {can|which will|that may}cer cells usually have molecules on their surface that can be detected by the immune system, called tumour-associated antigens (TAAs); they're often proteins or other macromolecules (e.g. carbohydrates). Active immunotherapy directs the system to attack growth cells by targeting TAAs. Passive immunotherapies enhance existing anti-tumor responses and include the use of monoclonal antibodies, lymphocytes and cytokines.

Session 4: Cancer Biomarkers

                                            

Protein Biomarkers are often used as biomarkers for early detection of cancers particularly used for the identification of carcinoma.

Diagnostic Patients with suspected pancreatic cancer will undergo an initial CT scan to determine if asuspect mass is localized and removed by surgery 63% of patients will be diagnosed with non-resectable stage III and IV disease and a diagnostic test are undertaken to verify carcinoma by H&E pathological analysis.

The presence of cancerous cells via pathology is extremely difficult because of high numbers of non-cancerous stromal infiltrating cells and administration of therapy or enrolment into a clinical test\ will only begin on definitive diagnosing of carcinoma.

These will notice specifically stains neoplastic pancreatic cells would enable the pathologist to confidently diagnose pancreatic cancer and thus offer appropriate cancer treatment to the patients. The Novel Biomarker BI-010 is known as a sensitive (98%) ANd specific (95%) IHC marker for carcinomaand gas-discharge tube is seeking a partner to develop an IHC primarily based test to detect BI-010 in fine needle aspirate biopsies from biopsy samples.

Session 5: Translational Oncology

 

Translational Oncology is the field of Cancer Research where a series of research conducted at the labs come out with a novel approach towards the cancer therapy. This branch of science involves many interdisciplinary subjects. Researchers here will have to be familiar with all the knowledge. This is considered to be the next big thing in Cancer Research with great no of employability and Commercial opportunities available. Translational research has advanced from recognizing a solitary change driving genome to the high-throughput cutting edge entire genome sequencing investigations. Late advances in Omics have expanded our insight into the procedures underlying malignancy development

Session 6: Radiation Oncology

 

It is one among the 3 basic specialties, the opposite 2 being surgical and therapeutic medical specialty, related with the treatment of development.

Radiation can be given as a therapeutic system, either alone or in combine with surgery or probably therapy. The mission of Advances in Radiation Oncology is to give unique clinical research went for improving the lives of people living with tumour and distinctive ailments treated with radiation treatment.  Radiation Therapy, Predictive Oncology, Cancer Imaging, Stem Cell Therapy, Oncology Nursing

 

Session 7: Cancer Metabolism

 

Cancer metabolism refers to the alterations in cellular metabolism pathways that are evident in cancer cells compared with most conventional tissue cells. Metabolic alterations in cancer cells are various and include aerobic glycolysis, reduced biological process and also the multiplied generation of synthesis intermediates required for cell growth and proliferation.

 

 

Session 8: Cancer Diagnosis

 

Cancer is considered to be the main reason for deaths across the world.

The cure for cancer is still a matter of research. However, there are few curing techniques available only if the person is diagnosed at the early growth stages. So cancer identification becomes a really necessary a part of associate individual’s survival. Since the cancer cells exhibit properties of a normal cell until it reaches malignant stages, it becomes difficult to diagnose. However few symptoms will act just like the signals for the cancer growth. Once these symptoms are encountered one can endure diagnosing techniques like diagnostic test, Radiography etc. Through these strategies, the practician are going to be ready to predict the stage of cancer and survivability of the patients.

Session 9: Cancer Immunotherapy & Vaccines

 

Cancer therapy (Immuno-oncology or Immunooncology) is that the use of the system to treat cancer. Immunotherapies can be categorised as active, passive or hybrid (active and passive). These approaches exploit the very fact that {can|which will|that may}cer cells usually have molecules on their surface that can be detected by the immune system, called tumour-associated antigens (TAAs); they're often proteins or other macromolecules (e.g. carbohydrates). Active immunotherapy directs the system to attack growth cells by targeting TAAs. Passive immunotherapies enhance existing anti-tumor responses and include the use of monoclonal antibodies, lymphocytes and cytokines.

Session 10: Cancer Biomarkers

 

Protein Biomarkers are often used as biomarkers for early detection of cancers particularly used for the identification of carcinoma. Diagnostic Patients with suspected pancreatic cancer will undergo an initial CT scan to determine if asuspect mass is localized and removed by surgery 63% of patients will be diagnosed with non-resectable stage III and IV disease and a diagnostic test are undertaken to verify carcinoma by H&E pathological analysis. The presence of cancerous cells via pathology is extremely difficult because of high numbers of non-cancerous stromal infiltrating cells and administration of therapy or enrolment into a clinical test will only begin on definitive diagnosing of carcinoma. These will notice specifically stains neoplastic pancreatic cells would enable the pathologist to confidently diagnose pancreatic cancer and thus offer appropriate cancer treatment to the patients. The Novel Biomarker BI-010 is known as a sensitive (98%) ANd specific (95%) IHC marker for carcinomaand gas-discharge tube is seeking a partner to develop an IHC primarily based test to detect BI-010 in fine needle aspirate biopsies from biopsy samples.

 

Session 11: Translational Oncology

 

Translational Oncology is the field of Cancer Research where a series of research conducted at the labs come out with a novel approach towards the cancer therapy. This branch of science involves many interdisciplinary subjects. Researchers here will have to be familiar with all the knowledge. This is considered to be the next big thing in Cancer Research with great no of employability and Commercial opportunities available. Translational research has advanced from recognizing a solitary change driving genome to the high-throughput cutting edge entire genome sequencing investigations. Late advances in Omics have expanded our insight into the procedures underlying malignancy development.

 

Session 12: Radiation Oncology

 

It is one among the 3 basic specialties, the opposite 2 being surgical and therapeutic medical specialty, related with the treatment of development. Radiation can be given as a therapeutic system, either alone or in combine with surgery or probably therapy. The mission of Advances in Radiation Oncology is to give unique clinical research went for improving the lives of people living with tumour and distinctive ailments treated with radiation treatment. Radiation Therapy,   Predictive Oncology, Cancer Imaging, Stem Cell Therapy, Oncology Nursing.

Session 13: Cancer Metabolism

 

Cancer metabolism refers to the alterations in cellular metabolism pathways that are evident in cancer cells compared with most conventional tissue cells. Metabolic alterations in cancer cells are various and include aerobic glycolysis, reduced biological process and also the multiplied generation of synthesis intermediates required for cell growth and proliferation.

Session 14: Cancer Epigenomics

 

Cancer epigenetics means studying of epigenetic modifications to genome of cancer cells that do not involve a change in the nucleotide sequence. Epigenetic corrections are important like genetic alterations, transition of a cell from normal to tumorous, and their manipulation holds great promise for cancer prevention, detection and therapy. In different cancers, a diversity of epigenetic mechanisms can be perturbed, such as silencing of tumor suppressor genes and activation of oncogenes by altered CpG island methylation patterns, histone modifications and dysregulation of DNA binding proteins.

Session 15: Cancer genomics

 

• Epigenetic influence on genomic stability

• Molecular underpinnings of therapeutic targets

• Aberrant DNA methylation genes

• Tumor heterogeneity

Session 16: Cancer Inflammation and Immune Tolerance

 

It is widely believed that chronic inflammation critically adds to cancer. Immune tolerance in cancer intermediates tumour escape from the immune system. Inflammation mediates tumor-induced tolerance. The induction and maintenance of the chronic inflammatory response is a universal mechanism of immune tolerance.

Session 17: Nanoparticles in Cancer Therapy

 

Since last decade nanoparticles have been of significant interest as they offer great benefits in drug delivery to overcome limitations present in case of conventional chemotherapy. Sizes ranges from (1-1000 nm) and also made by using a variety of materials including polymers, lipids, inorganic materials and biological materials. Targeted particles are used which are nano range to carry chemotherapeutic agents in cancer therapy, offers many advantages to improve drug/gene delivery and to overcome many problems associated with conventional chemotherapy.

Session 18: Novel Approaches to Cancer Therapeutics

 

The standard management modalities are associated with severe side effects and high toxicity which in turn lead to low quality of life. This encompasses novel strategies for more effective chemotherapeutic delivery aiming to generate better prognosis. Cancer treatment is a dynamic field and significant advances are being made in the development of novel cancer treatment strategies. The difference to conventional cancer therapeutics, novel approaches such as ligand or receptor based targeting, intracellular drug targeting, gene delivery, cancer stem cell therapy, magnetic drug targeting and ultrasound-mediated drug delivery, have extra new modalities for cancer treatment.

Session 19: Cancer Epigenetics

 

• Molecular Profiling Techniques

• New Biologics & Vaccines

• Chemical Proteomics

• Combination Strategies in Immuno-oncology

• Novel Biomarker Discovery

Session 20: Cancer Prevention & Therapy

 

Malignancy treatment represents the treatment of tumour in a patient, regularly with surgery, chemotherapy or potentially radiotherapy. Treatments are likewise available for some disease composes. A malignancy subject may get a wide range of treatment, including those going for mitigating the manifestations of disease, for example, torment. Chemotherapy, as a rule, alludes to the utilization of pharmaceuticals or medications to treat disease. The possibility of having chemotherapy panics numerous individuals. Be that as it may, realizing what chemotherapy is, the manner by which it works and what's in the store can frequently help quiet your feelings of trepidation. It can likewise can be superior of controlling over your disease treatments. Directed treatment is a unique sort of chemotherapy that exploits the contrast between typical cells and malignancy cells. It's infrequently applied alone, however, frequently other malignancy medications are utilized with a focused treatment.

Session 21: Chemotherapy

 

Chemotherapy (Chemo) is a sort of treatment that incorporates a pharmaceutical or blend of drugs to treat tumor. The objective of chemo is to stop or moderate the development of growth cells. Chemo is viewed as a foundational treatment. This implies it might influence your whole body. Chemo meds assault quickly developing malignancy cells, yet they can likewise influence solid cells that develop quickly. Chemotherapy is the use of any pharmaceutical to treat any malady. Regardless, to a large number of individuals, the word chemotherapy suggests drugs used for ailment treatment. It's every now and again condensed to "chemo." Surgery and radiation treatment expel, murder, or damage illness cells in a particular area, yet chemo can work all through the whole body. This infers chemo can pulverize harm cells that have spread (metastasized) to parts of the body a long way from the principal (fundamental) tumour.

Session 22: Cancer Immunology

 

As stated earlier, cancer research is an interdisciplinary subject; Cancer Immunology is a branch of science which deals with the role of host immunity and its behaviour to the growth of cancer. The immune system assistances to fighting against the foreign invaders. However, cancer cells not being foreign cells to the host are very difficult to be identified by the host immunity as a threat. Only when the cancer cells start to release certain molecules which are specific to the cancer cells, host immune cells try to act against the cancer cells.

Session 23: Hematology -Oncology

 

Hematologic Oncology is the branch of medical study about the diagnosis, prevention, treatment, and avoidance of disease identified with blood. Haematology is learning about etiologist which includes treating the disease that influences the production of blood and its parts, for example, platelets, haemoglobin, blood proteins, bone marrow, platelets, veins, spleen, and the component of coagulation. Haematologists study oncology and work with oncologists, individuals who may specialize just in that field rather than both-the therapeutic treatment of the tumor. There are different disorders that people are influenced by haematology. Different type of blood conditions that are looked at incorporate anemia, hemophilia, general blood clots, bleeding disorders, and so forth. Related blood diseases, leukemia, myeloma, and lymphoma, these are more serious cases that should be analyzed.

Session 24: Organ-Specific Cancers

 

One of the leading causes of death all over the world is Cancer. Organ Cancers are cancers named based on the location of cancer in the parts of the body. There are different types of cancers, some of them are Head and Neck Cancer, Brain cancer, Lung cancer, Oral cancer, Liver cancer, Breast cancer, Prostate cancer, Gastric cancer, Pancreatic cancer, Kidney (Renal Cell) cancer, Leukemia and many more.  Stomach, prostate, Lung, colon & rectum, and liver are commonly affected by cancer in men. In women most common organs affected are breast, colon, rectum, lung, cervix and stomach.

Session 25: Oncogenomics

 

The sub-division of genomics that characterizes cancer-associated genes is related to oncogenomics. It focuses on transcript alterations in cancer, genomic and epigenomics. The change from normal to aggressive cancer is thought to occur over a timescale of 5–20 years. This transformation is by both inherited genetic factors and somatic genetic alterations and mutations, and it results in uncontrolled cell growth and leads to death. The genetic mutations leading to cancer occur only in certain genes. Cancer  genes are classified as proto-oncogenes (e.g., the genes for MYC, ERBB2 and EGFR) and tumor suppressor genes such as the genes that encode TP53, CDKN2A, and RB. The sucess of the Human Genome Project simplified the field of oncogenomic and improved the abilities of researchers to find oncogenes. Global methylation profiling and sequencing technologies methods are practiced to the study of oncogenomics.

Session 26: Cancer Stem Cell Therapy

 

Stem cell transplantation is a procedure that reinstate blood-forming cells in people who have had theirs destroyed by the very high doses of chemotherapy or radiation therapy that are used to treat certain cancers. Blood stem cells are important because they grow into different types of blood cells.

 

• Stem Cells and Tumors

• Stem Cell Transplantation

• Bone Marrow Transplantation

• Cord Blood Stem Cells and Cancer

• Stem Cell Research

Session 27: Lifestyle changes

 

• Diet & Cancer

• Vaccinations

• Natural Therapy

• Psychological & Social Aspects

 


 

Attendee Criteria

Attendees would be active researchers, industrialists, scientists, associations, societies, PhD and post doc fellows, students, faculty, Subject experts and Entrepreneurs. Authors of accepted abstracts are pre-approved for registration. All other researchers must Sign up and register towards the conference.

A very limited number of spots are available for individuals in Keynote/Plenary positions.  Some of the Keynote and Plenary Speakers will have an opportunity to chair any session during the conference.

25 Oral presentation spots are available for 2-day events. The individual speaker is allowed to present a maximum of 2 talks at the conference.

 

Who Can Attend

Researcher/Academic /Industrial / Clinical / Private / Marketing

Researchers actively participating in basic science investigations, clinical studies, or epidemiologic research.

 

Physicians & Scientists who have faculty appointments at academic institutions including medical school programs, or practitioners who are involved in patient care or counselling.

 

Industries related to pharmaceuticals, Manufacturing, Services, Clinical can achieve visibility and credibility, exhibiting at a trade show has hundreds of benefits for your business. Establishing a presence, whether big or small, for your company at an exhibition gives you a powerful platform for meeting new customers, reaching out to your existing clients, and building a more established and reliable brand.

 

Clinical takes advantage of the educational and networking opportunities designed for hospital professional.

 

Marketers from generating new business to staying current with the latest trends, attending marketing events, meetings, and conferences can be crucial to the success of a company’s or individual’s growth strategy. There are some key benefits for why marketers should consider attending networking events.

 

1. Build Meaningful Relationships

2. Stay Current with Trends by Learning from Powerful Speakers

3. Connect with Influencers and in Turn, You’re Target Audience

4. Get Fresh Ideas and Solutions for Your Business.

 

Various sessions in our Conferences:

Plenary Talk: A plenary talk of a conference which all members of all parties are to attend. Such a session may include a broad range of content, from keynotes to panel discussions, and is not necessarily related to a specific style of presentation or deliberative process.





Keynote: This is a talk on a specific theme which represent the whole subject of the conference. Keynotes are usually delivered by Professors, President of associations, MD and above.



Oral Presentation: A presentation is a process of presenting a topic to an audience. It is typically a demonstration, introduction, lecture, or speech meant to inform, persuade, inspire, motivate, or to build goodwill or to present a new idea or product.



Delegate: One who gains knowledge, comprehension or mastery through experience or study; someone who learns or takes knowledge or beliefs; one that is learning; one that is acquiring new knowledge, behaviour’s, skills, values or preferences.



Poster Presentation: A poster presentation, at a congress or conference with an academic or professional focus, is the presentation of research information, usually peer-reviewed work, in the form of a poster that conference participants may view. A poster session is an event at which many such posters are presented.



Workshop: A workshop is designed to teach something or develop a specific skill while an academic conference is about presenting original research and getting feedback from peers. A workshop doesn't necessarily have to present original research; it is directed more towards teaching and learning in an interactive environment.



E-poster: An e-Poster or digital poster is a digital presentation of research that is presented within a congress.



Video Presentation: Animated or recorded video describing a research or review topic. Video talks for usually not more than 20-30mins)

 

Our Speakers


Larix Conferences 2019 - the day is designed to make it happen!.
Witness some of the great leaders, bright minds leading the industrial revolution and business innovators sharing insights on embracing the future and advancing their knowledge with scientific solutions.
Inspiring keynote presentations
Welcome Message

Prof Dato Sri Dr. Abu Hassan Assari Abdullah

MBBS, FRCS (EDIN), FAMM, FAMS

Dear Colleagues, Scientists, Students and Friends,

As a President of Malaysian Society for Traumatology & Emergency Medicine and organizing committee, I am honoured and delighted to welcome you to attend the Larix Conferences, which are scheduled from November 21-24, 2019 in Kuala Lumpur, Malaysia. Larix International in association with Geomatika University and Malaysian Society of Traumatology and Emergency Medicine brings together professors, students, Industry colleagues, scientists, researchers, associations, societies from around the globe to for discussing cutting-edge information for the development in the fields.

Being citizen of Malaysia I would assure that Kuala Lumpur is a great place for academic and networking purpose which invariably provides with both educational and fascinating new experiences. Acquire a great deal of knowledge of the modern culture of the city of Malaysia as a jam of the tradition and the modernism. Additionally, domestic and overseas participants could enjoy themselves with a variety of amusement facilities as a tourist before or after the congress.

All the conferences are designed to bring forth the most up to date information of innovation and development Key aspects will include Engineering, Medical, Clinical, Therapeutics, chemistry, Diagnosis, drug discovery & drug screening, and many other new potential topics that can be discussed through this process.

Please join your peers from around the world for this wonderful opportunity to reach the largest assembly of participants meet with thought leadership experts and share your new research, and show off your front-line research at this 2-day event.

We indeed look forward to see you in Kuala Lumpur, Malaysia.

Your presence and deliberation will make this conference remarkably successful in all aspects!

 

Regards,

Prof Dato Sri Dr. Abu Hassan Assari Abdullah

MBBS, FRCS (EDIN), FAMM, FAMS

Malaysia

advanced-journal-of-cancer-biology.png

Supporting Journals

Accepted authors are invited to submit a full paper for publication in one of the conference journals subject to the usual referring process of the journal. In addition, all accepted papers will be collectively published online in a virtual special issue

How-AV-companies-can-stand-out-amongst-the-crowd.jpg

Exhibitions & Sponsorship

With numerous branding and marketing opportunities across the world, no matter your business objectives or budget, you will be able to customize your sponsorship and exhibitor package to meet your requirements

Services_Strategy_SponsorExhibitorSalesStrategy_01_Header.jpg.jpg

Networking & Marketing

Conference is designed to create networking opportunities among like-minded peers and also provide opportunity to the build new partnerships and concepts

Venue & Updates


download.jpg

Kuala Lumpur, Malaysia


Kuala Lumpur is the capital of Malaysia. Its modern skyline is dominated by the 451m-tall Petronas Twin Towers, a pair of glass-and-steel-clad skyscrapers with Islamic motifs. The towers also offer... Read More
70480014.jpg

Holiday in Express


The first Hoiday Inn Express In Malaysia is Conveniently placed at Jalan Raja Chulan, this hotel is situated at the KL Downtown "Golden Triangle" area with easy access to major financial and commer... Read More
cancer 2.jpg

Cancer Updates


Over the past 25 years, the number of Americans who have died from cancer has dropped dramatically, though racial and economic disparities persist, a new study reveals. Read More

Attended by Industry Leaders


Media Partners


conference locate.jpg
vydha health.jpg
JPR info.jpg
Marin Magazine.jpg
Labepedia.jpg
logo-IJPBS.jpg
logo-IJLPR.jpg

Exhibitors


Gland Chemicals.jpg

Sponsors


PS 3 Lab.jpg
velarix Life sciences.jpg
Facebook
Pinterest
Twitter
LinkedIn
blog Blog
Youtube